title: Glutathione depletion in human and in rat multi-drug resistant breast cancer cell lines.
abstract: The effects of GSH depletion in a human breast cancer cell line and a multi-drug resistant subline (ADRr) were determined in a number of experimental conditions. The ADRr cells contained lower GSH concentration which cannot be explained solely on the basis of differences in cell kinetics, and yet the rate-limiting synthetic enzyme gamma-glutamylcysteine synthetase was increased 2-fold. Inhibition of GSH synthesis by BSO resulted in more rapid and more pronounced GSH depletion in ADRr compared to the wild-type cells, suggesting that enhanced GSH utilization and efflux in the resistant cells account for the lowered basal concentration. In addition, the gamma-glutamyl moiety salvage enzyme gamma-glutamyltranspeptidase was reduced markedly in the ADRr cell line. Since these cells have overexpression of the efflux pump protein P-glycoprotein, we examined the effects on cellular GSH of inhibition of the pump's function by verapamil. We found that verapamil significantly depleted cellular GSH. In a rat mammary carcinoma cell line selected in Adriamycin for multi-drug resistance, a similar molecular phenotype has been described including diminished cellular GSH concentration. Verapamil treatment of these cells also resulted in significant depletion of cellular GSH. These results are consistent with the recent report that combined treatment of BSO and verapamil has an additive effect on cytotoxicity. It is likely that decreased basal GSH concentration is due to oxidation and conjugation of it in reactions catalyzed by the enhanced peroxidase and GST found in these cells.
authors.affiliation: Department of Medicine, Montreal General Hospital, Quebec, Canada.
authors.forename: G
authors.initials: G
authors.lastname: Batist
authors.forename: R
authors.initials: R
authors.lastname: Schecter
authors.forename: A
authors.initials: A
authors.lastname: Woo
authors.forename: D
authors.initials: D
authors.lastname: Greene
authors.forename: S
authors.initials: S
authors.lastname: Lehnert
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism*; D019328:Buthionine Sulfoximine; D004317:Doxorubicin / Q000494:pharmacology; D004351:Drug Resistance; D005260:Female; D005978:Glutathione / Q000032:analysis* / Q000378:metabolism; D005982:Glutathione Transferase / Q000032:analysis; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism*; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology
chemical_list: D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D004317:Doxorubicin; D014700:Verapamil; D005982:Glutathione Transferase; D005978:Glutathione